Ekso Bionics Holdings, Inc. (EKSO) Stock Analysis & Investment Frameworks
Ekso Bionics Holdings, Inc. (EKSO) stock analysis on Invetso. Review Ekso Bionics Holdings, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Ekso Bionics Holdings, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Technology
- Industry: Information Technology Services
- Country: US
Ekso Bionics Holdings, Inc. Key Financial Metrics
- Market Cap: $38.57M
- Revenue: $12.80M
- ROE: -126.71%
- ROIC: -14.20%
- Dividend Yield: N/A
About Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.